Woodline Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Woodline Partners’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$1.08K	–	829
2022 Q4	$1.08K	Hold	400,000	–	–	﹤0.01%	737
2022 Q3	$3.93M	Hold	400,000	–	–	0.05%	343
2022 Q2	$3.91M	Hold	400,000	–	–	0.06%	296
2022 Q1	$3.9M	Hold	400,000	–	–	0.06%	276
2021 Q4	$3.88M	Hold	400,000	–	–	0.06%	319
2021 Q3	$3.88M	Hold	400,000	–	–	0.06%	298
2021 Q2	$3.9M	Buy	+400,000	New	+$3.92M	0.07%	254

Other funds holding AONC

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Woodline Partners's AONC Position: Q1 2023 in Review

Woodline Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 400,000 shares — an estimated $1.08K sold.

Woodline Partners first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $3.93M in Q3 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

Woodline Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 400,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.08K.
Woodline Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
Woodline Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $3.93M in Q3 2022.
13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.